Legal & General Group’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1K | Sell |
12,009
-79,838
| -87% | -$167K | ﹤0.01% | 2915 |
|
|
2025
Q1 | $157K | Buy |
91,847
+10,442
| +13% | +$17.8K | ﹤0.01% | 2640 |
|
|
2024
Q4 | $411K | Buy |
81,405
+13,293
| +20% | +$67.1K | ﹤0.01% | 2530 |
|
|
2024
Q3 | $371K | Buy |
68,112
+58,377
| +600% | +$318K | ﹤0.01% | 2559 |
|
|
2024
Q2 | $46.7K | Buy |
9,735
+3,928
| +68% | +$18.9K | ﹤0.01% | 2807 |
|
|
2024
Q1 | $18.1K | Sell |
5,807
-767
| -12% | -$2.39K | ﹤0.01% | 3007 |
|
|
2023
Q4 | $18.7K | Sell |
6,574
-641
| -9% | -$1.82K | ﹤0.01% | 3059 |
|
|
2023
Q3 | $21.1K | Buy |
7,215
+410
| +6% | +$1.2K | ﹤0.01% | 3003 |
|
|
2023
Q2 | $19.5K | Sell |
6,805
-251
| -4% | -$718 | ﹤0.01% | 3124 |
|
|
2023
Q1 | $21.8K | Sell |
7,056
-13,610
| -66% | -$42.1K | ﹤0.01% | 3043 |
|
|
2022
Q4 | $43.6K | Buy |
20,666
+5,167
| +33% | +$10.9K | ﹤0.01% | 2970 |
|
|
2022
Q3 | $51K | Sell |
15,499
-1,471
| -9% | -$4.84K | ﹤0.01% | 2969 |
|
|
2022
Q2 | $55K | Buy |
16,970
+3,364
| +25% | +$10.9K | ﹤0.01% | 2991 |
|
|
2022
Q1 | $96K | Hold |
13,606
| – | – | ﹤0.01% | 2880 |
|
|
2021
Q4 | $99K | Buy |
+13,606
| New | +$99K | ﹤0.01% | 2910 |
|